Zacks Investment Research on MSN
CVS' Aetna Wins Big on 2026 MA Star Ratings: How to Play the Stock?
On Thursday, the Centers for Medicare & Medicaid Services (“CMS”) released the 2026 Star Ratings for Medicare Advantage Prescription Drug (“MAPD”) plans. The five-star rating system evaluates Medicare ...
$0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies 1, $0 copay for colonoscopies and mammograms at in-network providers $0 copay for annual Healthy Home Visit from a licensed ...
Beneficiaries enrolled in Medicare Advantage and Part D drug plans might lose their coverage as UnitedHealthcare, Humana, and Aetna (CVS Health) scale back offerings for 2026.
Aetna®, a CVS Health® company (NYSE: CVS), announced today that over 81 percent of its Medicare Advantage (MA) members are in 2026 Medicare Advantage Prescription Drug (MAPD) plans that are rated 4 ...
The Louisiana Joint Legislative Committee on the Budget on Thursday approved more than $1.1 billion in emergency contracts for the state’s Office of Group Benefits, including new agreements with Blue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results